Mylan Laboratories To Refile Hatch-Waxman Suit Vs. FDA
Mylan Pharmaceuticals is preparing a new lawsuit against the U.S. Food and Drug Administration over the legality of so-called "authorized generics" after surprisingly withdrawing its original complaint earlier this week....To view the full article, register now.
Already a subscriber? Click here to view full article